Effects of PEEP on Heart and Lungs in Obese Subjects

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT02523352
Collaborator
(none)
35
1
1
56.9
0.6

Study Details

Study Description

Brief Summary

Aim of this study is to better understand pathophysiology of the alteration of respiratory mechanics and cardiovascular function in obese volunteer subjects. The investigators plan to test this hypothesis with a physiological, interventional study conducted on volunteers by using Electrical Impedance Tomography in a group of patients and magnetic resonance imaging (MRI) in another group.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Non-Invasive Ventilation
  • Procedure: Esophageal catheter positioning
N/A

Detailed Description

Obese subjects are prone to develop respiratory insufficiency when requiring mechanical ventilation. Atelectasis is the primary responsible for respiratory insufficiency and impossibility to wean obese patients from respiratory support. The investigators do believe that the respiratory system derangements observed in the previous study during the critical illness are already present, although in lower severity, in the obese patients in their basal condition.

This study will help to understand the standard cardiac and respiratory function of an obese non critically ill subject to better target the therapies during the management of the critical illness to reestablish the homeostasis of the system:

The investigator's hypotheses are:
  • To demonstrate if morbidly obese patients show atelectasis at spontaneous breathing in the supine position and whether the increase in lung volume following PEEP titration is due to alveolar recruitment rather than overdistention.

  • To measure regional variations in ventilation/perfusion coupling at different ventilator settings

  • To investigate the role of diaphragm position in the development/treatment of respiratory insufficiency due to increased pleural pressure

  • To test if reopening of lung atelectasis through the application o a recruitment maneuver and titrated PEEP level would lead to an improvement in right heart function.

  • To assess pulmonary circulation at different levels of PEEP.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
35 participants
Allocation:
N/A
Intervention Model:
Sequential Assignment
Intervention Model Description:
35 patients will be enrolled in this study. The study is divided in two phases: the first phase will evaluate the PEEP in 12 consecutive obese subjects and 6 healthy volunteers using Trans-thoracic echocardiography (TTE) and Electrical Impedance Tomography (EIT). The second phase will evaluate the PEEP in the other 12 consecutive obese subjects and 5 healthy volunteers using Magnetic Resonance Imaging (MRI).35 patients will be enrolled in this study. The study is divided in two phases: the first phase will evaluate the PEEP in 12 consecutive obese subjects and 6 healthy volunteers using Trans-thoracic echocardiography (TTE) and Electrical Impedance Tomography (EIT). The second phase will evaluate the PEEP in the other 12 consecutive obese subjects and 5 healthy volunteers using Magnetic Resonance Imaging (MRI).
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of Effects of Positive End-expiratory Pressure (PEEP) on Lung and Heart Functions in Spontaneous Breathing Obese Subjects.
Actual Study Start Date :
Apr 5, 2018
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment

Volunteers with a BMI > 35 Kg/m2 and central fat distribution, without any past medical history

Procedure: Non-Invasive Ventilation
Progressive increase in airway pressure to open lungs atelectatic regions.

Procedure: Esophageal catheter positioning
The esophageal tube (8 French diameter catheter) will be positioned in the larger nostril previous topical anesthesia

Outcome Measures

Primary Outcome Measures

  1. End Expiratory Lung Volume [Change from baseline [0 PEEP] to titrated PEEP level (30 minutes after baseline)]

    Difference in end expiratory lung volume measured in mL

Secondary Outcome Measures

  1. Work of breathing [Change from baseline [0 PEEP] to titrated PEEP level (30 minutes after baseline)]

    Difference in work of breathing will be measured as Joule/min

  2. Right heart volumes [Change from baseline [0 PEEP] at titrated PEEP level (30 minutes after baseline)]

    Difference in right heart and diastolic and end systolic volumes will be measured

  3. Heart ejection fraction [Changes from baseline [0 PEEP] at titrated PEEP level (30 minutes after baseline)]

    Difference in heart ejection fraction will be measured

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Have a photo identification document

  • BMI ≥ 35 kg/m2

  • Waist circumference > 88 cm (for women)

  • Waist circumference > 102 cm (for men)

Exclusion Criteria:
  • Psychiatric disturbances such as anxiety, depression, schizophrenia requiring pharmacological treatment or hospitalization in the last year

  • Subjects with any known condition, including claustrophobia or pain, which limits their ability to lie in the MR scanner for the duration of the research study

  • Known presence of esophageal varices

  • Recent esophageal trauma or surgery

  • Known Coagulopathy

  • History of pneumothorax

  • Pregnancy

  • Diabetes

  • Presence of prosthesis incompatible with MR

  • Thoracic diameter grater than 70 cm

  • Resting heart rate (HR) < 50 or > 120 bpm and/or systolic blood pressure < 90 or > 160 mmHg and/or peripheral oxygen saturation (SpO2) < 88%

  • Currently enrolled in another research study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Robert Kacmarek, RRT, PhD, Massachussets General Hospital
  • Principal Investigator: Lorenzo Berra, MD, Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Robert M. Kacmarek, RRT, PhD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT02523352
Other Study ID Numbers:
  • EIT-TTE-MRI-Obese
First Posted:
Aug 14, 2015
Last Update Posted:
Nov 17, 2020
Last Verified:
Nov 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 17, 2020